Quick Takeaways: Why It Matters? Viyash is using BioForLife as a front-end platform to scale its companion animal business in Europe, starting with Italy, one of the continent’s largest and fastest-growing pet health markets. Market-wise, the all-cash ...
Quick Takeaways: Why It Matters? This deal gives Merck Animal Health an early, exclusive window into a gene-therapy pipeline for chronic and age-related diseases in pets, while Rejuvenate Bio secures non-dilutive R&D support and a $6M financing round to advance its platform...
Quick Takeaways: Why It Matters? VetrixBio is testing a dual-action osteoarthritis therapy that targets both pain (NGF/TrkA) and cartilage degradation (ADAMTS-5) in dogs, rather than just providing analgesia. The clinical data in aged Beagles shows a single...
Quick Takeaways Why It Matters? Parnell strengthens its position in the controlled veterinary injectables segment, gaining preference among practices prioritizing safety-differentiated euthanasia agents. Visual dye innovation reduces medication errors, accelerating adopti...
Quick Takeaways: Why It Matters? Cosmos Health is using its established human healthcare brand C-Scrub to cross into the UK veterinary market with a 4% chlorhexidine antimicrobial wash that independently meets key European veterinary disinfectant standards. The market imp...
Quick Takeaways: Why It Matters? This deal is about scaling continuous infection-control tech into mainstream animal-health settings, not just adding another equipment line. By plugging Synexis DHP into Midwest Veterinary Supply’s national network, cli...
Quick Takeaways: Why It Matters? Prodogi is entering the canine oral-care space with a clinical-data–backed format that goes beyond treats and water additives by using a dissolvable strip to coat the entire mouth. The 14‑day study results give the pro...
Quick Takeaways: Why It Matters? Lick Sleeve is extending its vet-led recovery garment line to tiny dogs, closing a fit gap for toy breeds that often get overlooked by standard post-op products. This offer broader addressable base for its alternative-t...
Quick Takeaways: Why It Matters? This partnership is designed to scale Rebound High Performance PRP across the US veterinary market by combining epiq’s distribution reach with Vetirus’s product and regulatory credentials, removing a key barrier to adoption-access to e...
Quick Takeaways: Why It Matters? Lenivia strengthens Zoetis’ lead in monoclonal antibody–based pain management for dogs by adding a longer-acting OA option to its portfolio. Market-wise, a single injection providing up to three months of osteoarthritis pain...
